Upcoming Events

Retia Medical Receives U.S. Food and Drug Administration Clearance for its Innovative Argos Cardiac Output Patient Monitor

– Proprietary Multi-Beat Analysis™ (MBA) algorithm ensures superior hemodynamic monitoring accuracy via a non-invasive system that is easier and less costly to use – VALHALLA, N.Y., Dec. 17, 2018 (GLOBE NEWSWIRE) — Retia Medical, LLC, a medical device company focused on advancing the quality and clinical use of hemodynamic monitoring, today announced that its Argos […]

Read More